These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10739689)

  • 21. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
    Yen RF; Hung RL; Pan MH; Wang YH; Huang KM; Lui LT; Kao CH
    Cancer; 2003 Jul; 98(2):283-7. PubMed ID: 12872346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of FDG PET-CT in asymptomatic epithelial ovarian cancer with rising serum CA-125: a pilot study.
    Ghosh J; Thulkar S; Kumar R; Malhotra A; Kumar A; Kumar L
    Natl Med J India; 2013; 26(6):327-31. PubMed ID: 25073988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation.
    Chopra S; Laurie LR; Chintapalli KN; Valente PT; Dodd GD
    J Comput Assist Tomogr; 2000; 24(3):395-9. PubMed ID: 10864074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
    Flamen P; Lerut A; Van Cutsem E; Cambier JP; Maes A; De Wever W; Peeters M; De Leyn P; Van Raemdonck D; Mortelmans L
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1085-92. PubMed ID: 11088030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K
    Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary serous papillary carcinoma of the peritoneum: CT findings.
    Zissin R; Hertz M; Shapiro-Feinberg M; Bernheim J; Altaras M; Fishman A
    Clin Radiol; 2001 Sep; 56(9):740-5. PubMed ID: 11585395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT appearance of primary papillary serous carcinoma of the peritoneum.
    Stafford-Johnson DB; Bree RL; Francis IR; Korobkin M
    AJR Am J Roentgenol; 1998 Sep; 171(3):687-9. PubMed ID: 9725296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical location of metastatic ovarian carcinoma detected by (18)F-FDG PET/CT.
    Sagasta Urrutia J; Portilla-Quattrociocchi H; Garcia Hernandez D; Montero de la Peña A; Moreno Capdevila C; Tobalina Larrea I
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):58-60. PubMed ID: 26341423
    [No Abstract]   [Full Text] [Related]  

  • 32. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
    Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP
    Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report.
    Wright JD; Horowitz NS; Rader JS
    J Reprod Med; 2002 Nov; 47(11):933-5. PubMed ID: 12497684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-body PET with FDG is useful for following up an ovarian cancer patient with only rising CA-125 levels within the normal range.
    Kurokawa T; Yoshida Y; Kawahara K; Tsuchida T; Fujibayashi Y; Yonekura Y; Kotsuji F
    Ann Nucl Med; 2002 Nov; 16(7):491-3. PubMed ID: 12508842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal recurrence of colon cancer detected by positron emission tomography: report of a case.
    Yasuda S; Makuuchi H; Sadahiro S; Mukai M; Ishida H; Tokunaga N; Kimura T; Tajima T; Shohtsu A
    Surg Today; 1999; 29(7):633-6. PubMed ID: 10452242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of primary peritoneal serous papillary carcinoma initially presented by massive bilateral pleural effusions.
    Kaira K; Takise A; Endou K; Yanagitani N; Sunaga N; Mori M
    Eur J Gynaecol Oncol; 2006; 27(2):197-9. PubMed ID: 16620072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal serous papillary adenocarcinoma: report of four cases.
    Minami T; Nakatani K; Kondo S; Kanayama S; Tsujimura T
    Intern Med; 2005 Sep; 44(9):944-8. PubMed ID: 16258208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple nodular metastases in mesenteric panniculitis by uterine papillary serous adenocarcinoma (UPSC): CT appearance of a case.
    La Fianza A; Alberici E; Di Maggio EM; Preda L; Campani R
    Clin Imaging; 1999; 23(2):90-3. PubMed ID: 10416083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. F18-fluorodeoxyglucose-positron emission tomography for diagnosis of pelvic tuberculosis mimicking peritoneal carcinomatosis.
    Hwang JH; Kim SE; Lee JK
    Int J Gynaecol Obstet; 2009 Mar; 104(3):244-6. PubMed ID: 19038386
    [No Abstract]   [Full Text] [Related]  

  • 40. Three-dimensional power doppler ultrasound is useful to monitor the response to treatment in a patient with primary papillary serous carcinoma of the peritoneum.
    Su JM; Huang YF; Chen HH; Cheng YM; Chou CY
    Ultrasound Med Biol; 2006 May; 32(5):623-6. PubMed ID: 16677920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.